Ascendis Pharma (Brazil) Top Management
A1SN34 Stock | BRL 48.84 0.00 0.00% |
Ascendis Pharma employs about 639 people. The company is managed by 10 executives with a total tenure of roughly 1491 years, averaging almost 149.0 years of service per executive, having 63.9 employees per reported executive. Analysis of Ascendis Pharma's management performance can provide insight into the company performance.
Flemming Jensen Insider VP Quality |
Scott Smith Insider Sr CFO |
Ascendis |
Ascendis Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.2658) % which means that it has lost $0.2658 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6669) %, meaning that it generated substantial loss on money invested by shareholders. Ascendis Pharma's management efficiency ratios could be used to measure how well Ascendis Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Ascendis Pharma Workforce Comparison
Ascendis Pharma AS is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 126,823. Ascendis Pharma adds roughly 639 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Ascendis Pharma AS Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Ascendis Pharma AS Price Series Summation is a cross summation of Ascendis Pharma price series and its benchmark/peer.
Ascendis Pharma Notable Stakeholders
An Ascendis Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ascendis Pharma often face trade-offs trying to please all of them. Ascendis Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ascendis Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Flemming Jensen | VP Quality | Profile | |
Scott Smith | Sr CFO | Profile | |
Michael LLM | Chief VP | Profile | |
Jan Mikkelsen | CEO and President | Profile | |
Birgitte MD | Sr Affairs | Profile | |
Timothy Lee | Director Relations | Profile | |
Lotte Sonderbjerg | Sr Officer | Profile | |
Peter Rasmussen | VP Officer | Profile | |
Kennett Sprogoe | VP Research | Profile | |
Jens Okkels | VP Devel | Profile |
About Ascendis Pharma Management Performance
The success or failure of an entity such as Ascendis Pharma AS often depends on how effective the management is. Ascendis Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ascendis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ascendis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of Ascendis Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ascendis Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ascendis Pharma's management manipulating its earnings.
Ascendis Pharma Workforce Analysis
Traditionally, organizations such as Ascendis Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ascendis Pharma within its industry.Ascendis Pharma Manpower Efficiency
Return on Ascendis Pharma Manpower
Revenue Per Employee | 12.2K | |
Revenue Per Executive | 777.8K | |
Net Loss Per Employee | 600.3K | |
Net Loss Per Executive | 38.4M |
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |